Key Highlights:
- CME Group reported record revenue of $1.6 billion in Q1 2025, bolstered by significant growth across key segments.
- Analysts maintain a "Hold" recommendation with a one-year average price target of $272.07.
- GuruFocus estimates suggest a slight downside to the current market price based on GF Value assessments.
CME Group Inc. (CME, Financial) has taken the spotlight with its record-breaking revenue performance in the first quarter of 2025. The financial powerhouse achieved a remarkable $1.6 billion in revenue, driven by substantial growth across its interest rates, equities, and foreign exchange segments. This surge in revenue led to an impressive adjusted net income that exceeded $1 billion. Additionally, CME Group experienced robust international volume increases and unveiled new products aimed at strengthening its market foothold.
Wall Street Analysts Forecast
According to predictions by 15 analysts, CME Group Inc. (CME, Financial) is expected to reach an average price target of $272.07 over the next year, with estimates ranging from a high of $301.00 to a low of $219.00. This average estimate suggests a potential upside of 6.32% from the current share price of $255.89. Investors can explore more detailed projections on the CME Group Inc (CME) Forecast page.
The overall sentiment among 18 brokerage firms positions CME Group stock with an average recommendation of 2.6, indicating a "Hold" status. The recommendation scale varies from 1, representing a Strong Buy, to 5, indicating a Sell.
GF Value Estimation
With insights from GuruFocus, the estimated GF Value for CME Group in a year's time is $252.55. This figure highlights a potential downside of 1.31% from the current trading price of $255.89. The GF Value is a proprietary calculation by GuruFocus that represents the stock's fair trading value. It's derived from historical trading multiples, past business growth, and future performance forecasts. For an in-depth analysis, visit the CME Group Inc (CME, Financial) Summary page.
